ProposalForge· Atlas
Renseignements gratuitsarrow_forward
Atlas/B & B BIOMEDICAL INC./National Research Council Canada
Atlas \u00b7 Fournisseur \u00D7 Minist\u00e8reProfil croisé

B & B BIOMEDICAL INC. × National Research Council Canada

Historique des contrats et analyse des dépenses entre B & B BIOMEDICAL INC. et National Research Council Canada.

auto_awesome
Tracking this entity every week?
Watch this entity, get an email digest the moment they win, lose, or are recompete-eligible. Free on every plan.
Watch entity (free)arrow_forward

Total Contracts

3

Total Value

$123.6K

Competitive %

100%

Fiscal Years Active

3

2011-2012-Q1 to 2019-2020-Q1

Solicitation Breakdown

Competitive: 100% (3)
Non-competitive: 0% (0)

Commodity Breakdown

Commodity TypeContractsTotal Value
G1$79.9K
Unknown2$43.7K

Contracts

DateValueDescriptionCommodityDetails
2019-06-10$79.9KMeasuring, controlling, laboratory, medical and optical equipment and partsGView
2013-09-24$24.7KOTHER BUILDINGS (SPECIFY)--View
2011-06-27$19.0KMEASURING, CONTROLLING, LABORATORY, MEDICAL AND OP--View
B & B BIOMEDICAL INC. full profile →

View all contracts, departments, and spending breakdown for this vendor.

National Research Council Canada full profile →

View all contracts, vendors, and spending breakdown for this department.

Explore More Government Data

National Research Council Canada Budget

Budget and spending data for National Research Council Canada

National Research Council Canada Contracts

Federal contracts awarded by National Research Council Canada

IT Spending by Department

Federal technology budgets and consulting spend trends

Departmental Budgets

Budget breakdowns for every federal department and agency

Grants & Contributions

Federal grants from ISED, NRC, and regional development agencies

Contract Awards

Track who wins government contracts and award patterns

Standing Offers

Browse TBIPS, ProServices, and other procurement vehicles

Buy Canadian Policy

Guide to the 2025-2026 domestic procurement policy

Indigenous Procurement

PSAB, mandatory set-asides, and the 5% target